Form4.ai tracks every SEC insider trade in real time. See every AVTX insider filing with a free account — no card.
See every AVTX insider filing — free account, no card.
Free accountAvalo Therapeutics, Inc. (AVTX) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $2.2M. Most recent filing: Oct. 2, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 18, 2026 SEC filing | Sullivan Christopher Ryan Chief Financial Officer | Cashless exercise | $79,985 | — |
| Sep 11, 2026 SEC filing | Sullivan Christopher Ryan Chief Financial Officer | Cashless exercise | $97,569 | — |
| Sep 1, 2026 SEC filing | Doyle Mittie Chief Medical Officer | Cashless exercise | $8,121 | — |
Create a free account to see all 9 AVTX filings from the last 90 days. No card needed.
Create free accountWant AVTX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.